Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Deming David H bought 12,000 Phio Pharmaceuticals Corp. shares (Form 4)
Traded Nov 12 to Nov 13, 2026 · Filed Nov 16, 2026
From Nov 12 to Nov 13, 2026, Deming David H (Director) bought 12,000 Phio Pharmaceuticals Corp. shares at an average US$0.82 for US$9,823, leaving 61,800 shares. Filed Nov 16, 2026 (Form 4).
- Bought
- 12,000 shares
- Price
- US$0.82 average (US$0.81 to US$0.83)
- Value
- US$9,823
- Holding after
- 61,800 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Common Stock, $.0001 par value | Buy | 9,000 | US$0.81 | 58,800 | Direct |
| Nov 13, 2026 | Common Stock, $.0001 par value | Buy | 3,000 | US$0.83 | 61,800 | Direct |
Source
Download original · View original at SEC
Related
- Phio Pharmaceuticals Corp.
- Deming David H
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Deming David H · Nov 12, 2026
- Schedule 13G/A · CVI Investments, Inc. · Nov 16, 2026
- Form 4 · Plott Ronald Todd · Nov 10, 2026
- Form 4 · Bitterman Robert J · Nov 10, 2026
- Form 4 · Plott Ronald Todd · Sep 30, 2026
- Form 4 · Bitterman Robert J · Sep 29, 2026